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Abstract 
Cancer represents one of the costliest and most prevalent diseases to afflict the modern world, 
even though treatments have evolved steadily over the years and produce an increasingly 
positive outlook with each development and innovation. Essential oils have been used 
medicinally- among other purposes- for thousands of years and have begun to attract attention 
for possible applications to the field of oncology. Numerous investigations and publications have 
shed light on the possible chemopreventative (antioxidant and antimetastatic) uses of these oils, 
alongside cancer suppressive (apoptosis-inducing and cytotoxic) abilities that they may possess. 
With the high annual incidence of cancer and the ever-rising price of treatment, clinical 
application of essential oils may transform into a viable and effective compliment to current 
treatments.  
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Possible Roles for Essential Oils in Chemoprevention and Suppression of Cancer 
Introduction 
An assortment of claims and assertions have been made regarding the perceived 
medicinal effects of essential oils (EO), including soothing abilities, alleviating intestinal or 
headache pains, antidepressant activity, and preventing or even treating various forms of cancer 
(Barocelli et al., 2004). These claims reach far back into human history, well before the 
biochemical bases of their abilities could be understood. An example of such a history is found 
with camphor and its naturally derived oils which were widely used during the time of the Black 
Death in 14th century Europe for fumigation, as they were believed to have certain illness-
preventing effects (though their actual antimicrobial and disinfectant capacities would not be 
understood for several hundred more years) (Chen, Vermaak, & Viljoen, 2013). EOs have 
undergone a significant evolution over hundreds of years in terms of their ascribed uses and the 
available scientific understanding of their mechanisms of actions. Many of the claims concerning 
these products have not been substantiated scientifically, prompting opposition from regulatory 
agencies such as the FDA to their use in traditional medical applications (Mitchell, 2014). 
Nonetheless, while transformed in nature with time, EOs remain a common topic of discussion in 
the realm of holistic and natural approaches to medicine. 
Whereas the aromatherapeutic and antimicrobial effects of numerous different EOs have 
been topics of study for many years, investigation into EOs as a supplementary approach to 
cancer prevention and treatment is a topic of high interest which has emerged with the growth in 
understanding of cancer biology in the modern era. When taking into account the immense cost 
of cancer care and the large demographic afflicted by the disease, any possible amelioration to 
the current state of treatment and prevention are valuable areas of investigation. 
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This literature will seek to address the biochemical basis of the roles EOs may play in 
cancer prevention and treatment and provide an assessment of the current state of knowledge 
concerning their contribution to oncology as supplementary treatment options. With considerable 
research performed in recent years regarding oncological applications of natural products, EOs 
merit an appropriate assessment of their broad-scope application to the field of oncology. 
Definition and History Essential Oils 
The Nature of Essential Oils 
To properly understand EOs in the context of oncological applications, it is important to 
first understand the origins and nature of these oils. Much mysticism has existed surrounding 
EOs, including their extraction and purification processes, their chemical makeups, and their 
mechanisms of action. 
Today, EOs are defined as the product of some form of distillation (be it 
hydrodistillation, steam distillation, or some alternative form) or a mechanical process that 
causes the tissue matrices to release their volatile fractions- a mixture of easily vaporizable 
compounds under suitable conditions (Alzamora et al., 2010). Under this definition, the makeup 
of EOs cannot be defined as variations of a single chemical compound, but rather as mixtures of 
a variety of compounds that vaporize readily under favorable conditions. Commonly comprised 
of lipophilic plant metabolites, the identities of the chemical components of EOs vary widely 
between oils, but generally have similar chemical characteristics and molecular weights 
(typically under 300 amu) (Turek & Stinting, 2013). In fact, the number of compounds that 
comprise a given oil may range from just a few to in the hundreds, with their relative 
concentrations determining the characteristic smells, tastes and other qualities of each oil; these 
characteristics are known to even vary from plant to plant depending on the growth conditions of 
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the given plant and the extraction process employed (Turek & Stinting, 2013). For example, two 
peppermint plants grown in different regions may both yield peppermint EO, though the 
conditions under which the plants grew and the manner in which the peppermint oil was isolated 
may produce two oils that vary noticeably in their relative concentrations of their constituents. 
Among chemical constituents a wide range of chemical classes are represented, including 
ketones, aldehydes, alcohols, phenols, oxides, esters and a variety of unsaturated hydrocarbons 
(Turek & Stinting, 2013). Many EOs are found to contain terpenoids (unsaturated derivatives of 
terpene containing a number of linked isoprene subunits), which include such compounds in their 
mono-, bi-, tricyclic mono-, and sesquiterpenoid forms (Turek & Stinting, 2013). Diterpenes are 
relatively low in concentration in most EOs due to the volatility arising from their relatively low 
molecular weights which causes their loss during most distillation procedures (Turek & Stinting, 
2013). Nonetheless, diterpenes still represent a significant component in a large number of oils. 
Aliphatic derivatives of short hydrocarbons are often seen in significant quantities in EOs, 
though they contribute to the oils’ characteristics in a lesser manner than terpenoids (Turek & 
Stinting, 2013). Due to their hydrophobic structures, many oil constituents are low in aqueous 
solubility, and thus must form emulsions via interaction with surfactants (Boire, Reidel & 
Parrish, 2013).  
History of Essential Oils 
The dawn of production and use of EOs extends as far into history as Ancient Egypt 
around 4500 BC where they were commonly employed in herbal medicine and preparing 
cosmetics (Elshafie & Camele, 2017). Records indicate the incorporation of EO into medical 
practices of Ancient China and India between the years of 3000 and 2000 BC- a time during 
which a list of over seven hundred oils were considered to be viable medicines (Elshafie & 
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Camele, 2017). The Greeks did not begin to employ EOs until about 400 BC, though their oils 
represented those from a new population of plants found in the Mediterranean, further expanding 
the origins from which these oils were extracted (Elshafie & Camele, 2017). EOs were deemed 
so valuable in their applications ranging from combatting inflammation to treating infection that 
ancient Hebrews called myrrh “holy oil” and considered it of greater monetary worth than gold 
(Boire, Reidel & Parrish, 2013). Ancient Egyptian priests buried King Tutankhamun with 350 
liters of aromatic oils as a symbol of its worth (Boire, Reidel & Parrish, 2013). Historical texts, 
including the Bible, make frequent mention of aromatic oils, serving as a testament to the 
common application of these compounds for daily medicinal use (Boire, Reidel & Parrish, 2013). 
Applications at the time often included treatment for joint pain, wounds, skin sores, burns and 
even larger ailments such as leprosy or sexually transmitted diseases (Boire, Reidel & Parrish, 
2013). 
In the 19th century, a number of vegetable EOs were included in the Romanian 
pharmacopoeia, and the Institute of Medicinal Plants was founded in 1904 (Vinatoru et al., 
1996). Commercial production and sales of EOs began in the 1940’s with world-wide interest 
and exploitation expanding ever since (Vinatoru et al., 1996). Over the many years of EO 
production, the methods of extraction have varied greatly, with modern investigation and 
suggestion of genetically modified plants that yield greater quantities of oil constituents to 
further improve current production methods (Bertoemu, Sales, Ros, Arrillaga & Segura, 2007). 
Ancient methods included a technique known as enfleurage, in which plants were combined with 
solid, odorless purified fats and allowed to absorb the volatile compounds released by the plant 
(Cortez-Pereira, Baby & Velasco, 2010). With time and the development of technology, this 
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technique was replaced with alternatives such as various forms of distillation and solvent 
extraction (Cortez-Pereira, Baby & Velasco, 2010). 
As seen with innumerable technologies, medicinal practices, and processes, the 
production, uses and understandings of EOs have undergone a dramatic transformation over the 
many years of their exploitation by humankind. Recognition of this evolution serves to highlight 
the long-standing value that EOs have maintained and shed light on the significance of 
investigating their ascribed medicinal abilities. Oncological use of these natural products is one 
such field. 
In order to fully understand application of EOs to oncology, it is first important to explore 
the mechanisms of cancer development and proliferation. In light of the molecular biology of 
cancer, the relevance of EOs as a possible addition to current treatment methods may be 
clarified. 
Cancer 
The onset, treatment, prevention, and cost of cancer is an extremely prevalent topic in 
classrooms, laboratories, media, and household conversations alike. Of course, modern 
technology has brought- and continues to bring- new methods of disease detection and the ability 
to treat an ever-wider array of types of cancer by employing an ever-growing set of procedures, 
drugs and therapies. Nonetheless, modern medicine has yet to “cure” cancer, nor provide 
completely effective treatment or prevention options for the many forms of cancers that may 
arise in an individual. As such, the incidence of cancer occurrence is still high, even if the 
outlook of a cancer diagnosis in today’s medical age may be much more desirable than one in 
years prior. As cancer continues to be a major treatment need globally, expansion is continually 
needed in current understanding of its molecular biology and means of counteracting its negative 
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effects on those afflicted. As such, the possibility of using EOs alongside other treatment 
methods offers another beacon of hope in expansion of current methods to hopefully improve the 
current outlook of diagnoses and cost of remediating them. 
The Cost of Cancer Care 
The total cost of cancer care is projected to total $173 billion in 2020 in the United States 
alone (Mariotto, Yabroff, Shao, Feuer & Brown, 2011). Although rapid development in the 
1990’s in the field of oncology led to a dramatic decrease in cancer incidence and an increase in 
survivability, the net cost of care also climbed significantly (Mariotto, Yabroff, Shao, Feuer & 
Brown, 2011).  
According to the American Cancer Society, cancer deaths dropped by 22% between 1991 
and 2011 (Siegel, Miller & Jemal, 2015). However, an increase of approximately 75% in the 
overall cost of cancer treatment was also observed in the years 1995 to 2004, believed to be 
largely attributable to the development of surgical techniques and pharmaceuticals which were 
effective but increasingly costly; in 2004 this cost accounted for just under 5% of the United 
States total medical care costs (Mariotto, Yabroff, Shao, Feuer & Brown, 2015). As oncology 
continues to grow as a discipline, the inverse relationship between cancer deaths and treatment 
cost continues to grow. Each reduction in deaths attributable to cancer is met with an increase in 
the per-capita cost of doing so.  
The high national cost is understandable considering cancer’s place as the second leading 
cause of death in the United States (and many other countries), with the expectation it will 
surpass heart disease in the near future to become the leading cause of death (Siegel, Miller & 
Jemal, 2015). As a result, the dialogue surrounding cancer care warrants expansion beyond how 
to improve cancer care and outlook (an indubitably important discussion). In what ways could 
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improvements continue to be made without drastic increases in cost? What natural methods may 
be employed to aid treatment? How may one mitigate the negative side effects (such as 
recoveries from invasive surgeries or the side-effects of chemotherapy) of existing treatments 
while still providing the highest quality care? 
 EOs certainly do not offer an answer-all to this predicament. However, should viable 
implementations of these natural compounds be found to aid in cancer treatment or prevention, 
they are low-cost, natural, renewable additions to current methods, and may provide an 
opportunity to improve current care without reducing affordability. As such, this study intends to 
identify current literature which demonstrates the preventative and treatment capacities which 
essential oils may offer as a holistic addition to modern approaches to cancer care.  
Molecular Biology of Cancer 
Nevertheless, the field of oncology is extremely complex and the task of preventing or 
treating cancer is made difficult by the various mechanisms which cause cancer to arise and 
proliferate. In a broad sense, cancer development is rooted in genetic mutations which foster 
uncontrolled cell growth and tumor propagation (Fenech, 2002). However, to stop at this 
definition is an oversimplification of the intricate molecular biology dictating cancer. A 
comprehensive examination of the underlying causes of cancer’s onset and progression is beyond 
the scope of this literature, though a number of key portions are essential in understanding the 
application of EOs to oncology.  
Normal physiology of somatic cells is tightly regulated in terms of cell’s regulation 
through regular cycles of growth and division, dictated differently in tissues throughout the body. 
However, a number of factors may afflict this careful regulation and cause cells to exist in a state 
of deregulated growth and division (Fenech, 2002). Altered gene expression may be caused by 
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events such as gene mutation, rearrangement of chromosomes, and chromosomal nondisjunction, 
which cause one or more of the genes responsible for regulation to be affected (Fenech, 2002). 
As a result, expression of a given protein involved in the normal cell cycle may be increased or 
decreased such that the cell begins to divide rapidly, proliferate abnormally, and disrupt the 
normal physiology of the tissue, organ, and organism (Fenech, 2002). Proteins such as p53, 
which suppresses tumor formation and slows growth, may be decreased in expression, whereas 
proteins such as certain transcription factors and protein kinases may be upregulated and support 
uncontrolled growth (Li, Sun & Wang, 2017). 
 
Figure 1. Changes in gene expression allow uncontrolled cell growth. Genetic mutations and 
alterations arise from a number of sources (mutations, chromosomal nondisjunction or 
rearrangement, strand breakage, etc…) which affect their expression and ability to accurately 
code for their protein. Proteins responsible for tight regulation of progression through the cell 
cycle are insufficiently produced, causing dysregulation of the cycle, permitting rapid divisions. 
Genes encoding proteins needed for normal growth and division, such as certain transcription 
factors or protein kinases, may become over expressed and produced in excess, permitting 
proliferation.  
  
Causes of Cancer Onset 
Almost all cancers have been shown to exhibit high rates of what are known as reactive 
oxidative species (ROS), which have subsequently been heavily implicated in tumorigenesis 
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(Liou & Storz, 2009). ROS induce what is called oxidative stress on the cells in which they are 
found, in turn causing damage to cellular structures such as DNA, proteins and organelles; 
damage to DNA often ends with mutations which may vary in severity yet commonly cause 
carcinogenesis (Kumari et al., 2018). Alongside elevated ROS levels, cancer cells often express 
high levels of antioxidant capacity as well to survive and prevent ROS activity from causing cell 
death (Kumari et al., 2018). 
ROS arise in a variety of manners. They are a normal yet toxic byproduct of oxidative 
phosphorylation, which may be amplified when initial electron carriers within the electron 
transport chain remain reduced (such as in the case of excessive caloric intake), yielding the 
undesired product of superoxide, O2- (Wallace, 2005). Although this ion is converted to 
hydrogen peroxide in the mitochondrial matrix, it may be further converted into a hydroxyl 
radical in the cytosol, a highly reactive ROS, which may then induce oxidative stress and 
damage upon the cell (Wallace, 2005). Mitochondrial superoxide production is believed to be the 
largest producer of cellular ROS, consuming as much as 1% of the cell’s total oxygen intake in 
the production of superoxide alone (Sullivan & Chandel, 2014). This is one of a number of 
endogenous sources of these species, which may be extended to include the endoplasmic 
reticulum and peroxisomes as other sources (Phaniendra, Babu Jestadi & Periyasamy, 2015). A 
variety of exogenous sources are also widely implicated in the creation or supply of ROS and 
include environmental effects such as smoke, heavy and transition metals, radiation, pesticides, 
and air pollution as well as lifestyle choices such as alcohol, tobacco use or use of certain drugs 
(such as paracetamol) (Phaniendra, Babu Jestadi & Periyasamy, 2015). 
Nonetheless, the relationship between ROS and cancer biology is one that almost appears 
self-contradictory. The paradox of ROS and its effects on normal and cancerous tissues often 
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appears to invert depending upon conditions. The effect of DNA mutation on the part of ROS’s 
is well characterized to increase the likelihood of cancer proliferation. However, a number of 
chemotherapeutic treatments employ species that augment cancer cells’ existing levels of 
oxidative stress in attempt to abate the disease (Schumacker, 2006). Such treatments function by 
causing ROS levels to surpass a survivable limit and cause cell death in their excess, ideally 
causing cessation or reduction of the cancer (Schumacker, 2006). A preliminary excess of ROS 
may cause the onset of cancer, though its augmentation serves as a possible mechanism of 
inducing apoptosis and combatting the disease. As such, treatments to reduce ROS levels within 
the cell hold better roles as prevention methods, and those which increase ROS levels as a form 
of treatment (Sullivan & Chandel, 2014). 
Essential Oils in Cancer Care 
Current State of Essential Oils in Medicine 
In some senses, EOs have already taken the stage in the world of cancer treatment, 
though their role continues to evolve as it has over the last several thousands of years since their 
use became popular. Though many will contend that some current uses of EOs in this field have 
ambiguous definitions or mechanisms, current implementations of EOs in this field include 
relieving fatigue, reducing anxiety, improving emotional stress, and alleviating pain or muscular 
tension (Boehm, Büssing & Ostermann, 2012). Forms of use typically include topical 
application, dilution and use in massage therapy, inhalation via use of an atomizer or humidifier, 
and even ingestion in teas or some foods (Boehm, Büssing & Ostermann, 2012). 
Developments in the middle of the twentieth century brought improvements to the field 
of organic chemistry which made synthetic production of medicines more prevalent, causing a 
reduction in the medicinal use of EOs (Shaaban, El-Ghorab, Shibamoto, 2012). However, 
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consumer concern over synthetic compound toxicity has caused an increased interest in natural 
products with antioxidant, antimicrobial, anti-inflammatory and anticarcinogenic activities 
(Shaaban, El-Ghorab, Shibamoto, 2012).  
In light of the prevalence and cost of cancer care, and the widespread interest in EOs, it is 
worth investigating the possible implementation of expanding EO use beyond these listed uses. 
This literature seeks to summarize current knowledge and investigate some specifics surrounding 
chemoprevention and suppression of cancer using EOs of various plants as a complementary in 
oncology. In short, EO use in oncology may be considered a twofold approach: chemoprevention 
and cancer suppression. Much research has been conducted to clarify possible roles of EOs in 
both of these oncological applications with the interest of identifying ways in which EOs may 
prevent (chemoprevention) or suppress cancer cell growth. Such studies will be discussed in this 
literature.  
Cancer Suppression and Essential Oils 
Essential Oils and Induction of Apoptosis. Programmed cell death is a normal part of 
life in any organism responsible for the destruction of up to 70 billion cells per day in the 
average adult (Reed, 1999). Failure to undergo programmed cell death when appropriate, by 
either apoptosis or autophagy, fosters tumorigenesis by extending life spans of damaged cells 
and offers greater opportunity for mutagenic activity to manifest and spread (Reed, 1999). As a 
result, methods of inducing apoptosis are commonly pursued as a means to combat cancer and 
comprise a large number of currently existing treatments. As such, these apoptotic methods are 
an avenue of research that has been assessed in light of EO application (Pavithra, Sreevidya & 
Verma, 2009). 
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One such study sought to illuminate apoptosis induction using EO derived from 
Pamburus missionis- a thorny shrub indigenous to India and Sri Lanka (no common name) 
(Pavithra, Sreevidya & Verma, 2009). This plant had been previously investigated for the 
antimicrobial effects conferred by its ability to cause outer membrane disintegration and lysis of 
the cytoplasmic membrane (Pavithra, Sreevidya & Verma, 2009; Helander et al., 1998). These 
characteristics of P. missionis then led investigators to investigate apoptotic applications.  
Chemotherapeutic use of this plant’s EO was assessed on solid and leukemic cancer cell 
lines, including cancers of the colon, breast, and skin. Solutions of cells were subjected to varied 
concentrations of the EO and cytotoxic activity assessed via MTT (3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide) assay (Pavithra, Mehta & Verma, 2018). Nuclear morphology 
was assessed following treatment with EO, and progression through the cell cycle and apoptotic 
activity were analyzed via flow cytometry (Pavithra, Mehta & Verma, 2018).  
A number of significant results were garnered from this experiment. In some cell lines, 
EO treatment was consistently shown to induce DNA fragmentation- a hallmark of apoptosis 
(Pavithra, Mehta & Verma, 2018). Additionally, flow cytometry data suggested EO treatment 
resulted in cell death through both early and late apoptosis (Pavithra, Mehta & Verma, 
2018).Furthermore, an increase of up to 88% in ROS quantity within cells was observed 72 
hours after EO treatment- a trend found to occur in multiple cell lines studied here (Pavithra, 
Mehta & Verma, 2018). Increase in ROS concentration within the cell is commonly observed 
during apoptosis, and thus ROS increases may serve as a reliable indication of the process (Jeong 
& Joo, 2016). As previously discussed, observation of this apoptotic occurrence has led to the 
pursuit of pharmaceuticals with the ability to increase intracellular ROS (such as cisplatin) to 
serve as a possible means of combatting tumorigenesis, even though it also serves as source of its 
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initial onset (Jeong & Joo, 2016). As such, the multifaceted effects of the P. missionis EO led 
researchers in this study to suggest its use in the treatment of epidermoid skin cancer cells, 
though such implementation would require further investigation (Pavithra, Mehta & Verma, 
2018). This experiment was performed on cell cultures which provide an excellent view into the 
molecular biology of EO use in oncology but cannot yet fully reflect its performance within the 
human body, or in vivo.  
Another EO that has been investigated in light of apoptotic mechanisms of cancer 
treatment is derived from gum resins of the Burseraceae tree family, namely Boswellia sacra. In 
their 2011 publication, Suhail and colleagues discovered the ability of Boswellia sacra EO to 
induce localized cytotoxicity and apoptosis specified to tumor tissues (Suhail et al., 2011). 
Human breast cancer cell lines were used for this research and were treated with 1:1,600 
dilutions of the EO distillate. Elevated levels of cell-death shortly after treatment, assessed via 
quantification of lactate dehydrogenase release, were observed in all cell lines used when 
compared to controls (Suhail et al., 2011). Following this assay, researchers further assessed 
apoptosis induction following EO treatment, and found that DNA fragmentation was widely 
prevalent in treated cells (Suhail et al., 2011). DNA isolated from treated cells yielded a 
phenomenon known as DNA laddering following electrophoresis- an occurrence observed in the 
case of DNA fragmentation and production of a gamut of different-sized fragments (Suhail et al., 
2011). Apoptotic induction of a number of nuclear endonucleases produces small DNA 
fragments which, when resolved in a gel, form the basis of what are known as ladder assays; 
these assays have become widespread as a means of fast apoptosis-screening due to their ease of 
use and relatively low cost (Saadat, Saeidi, Vahed, Barzegari, & Barar, 2015).  This breakdown 
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of genomic DNA renders a cell unable to survive or proliferate, and thus serves as a reliable 
preliminary measure of apoptosis. 
Furthermore, this research looked at levels of caspase-8 and caspase-9, members of the 
cysteine protease family widely implicated in apoptotic pathways (Suhail et al., 2011). Within 
one hour of EO treatment, elevated levels of both caspases were found in some human breast 
cancer cell lines used for this assessment, though the elevated levels were not detected in all cell 
lines (Suhail et al., 2011). Although it would be ideal to find an EO whose function is ubiquitous 
in all types of cancers, the need for unique approaches for the many types of cancers is 
illuminated by this result. This helps to highlight the treatment opportunities that may be found 
in EO exploitation, though also serves as a reminder that EOs cannot serve as a fix-all or 
universal treatment. Rather, their promising effects are best considered an extension of current 
methods. 
Caspase-3 is also outlined in this study as the agent either mostly or entirely responsible 
for the cleavage of several targets involved in apoptosis; within one hour of treatment with 
Boswellia sacra EO, levels of caspase-3 were also observed to have increased in one cell line, 
though not in all cell lines used (Suhail et al., 2011). In addition, one of the targets of caspace-3, 
poly (ADP-ribose) polymerase (PARP), was found to be cleaved and inactivated over the same 
time frame (Suhail et al., 2011). PARP represents a family of proteins with functions ranging 
from catalyzing transfer of ADP-ribose onto select proteins to the chromatin structure 
modulation and DNA repair (Morales et al., 2014). Cleavage of PARP reduces the ability of the 
cell to repair DNA damage during the onset of apoptosis, further reducing the cell’s chances of 
survival and increasing the likelihood of successful apoptosis (Morales et al., 2014). As a result, 
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an increase of caspase-3 supplements mechanisms of cell death and may serve as a synergistic 
EO-based treatment strategy.  
To further elucidate accurate in vivo effects of EO treatment on cancer cells, self-
assembled tumor spheroids were assessed following treatment. It was observed that the treatment 
inhibited spheroid development, a major feature of cancer malignancy, via disruption of cellular 
network formation (Morales et al., 2014). This test showed the translational relevance of EO 
treatment from cell culture solutions in 96-well plates into a form that is more clinically 
applicable.  
 However, the apoptosis-inducing effects currently found in EO-treatment are not 
exclusive to DNA damage. In one study by Frank et al., frankincense oil was shown to reduce 
viability of bladder transitional carcinoma cells in the absence of damage to the genome; rather, 
there was an apparent alteration of expression of a number of genes implicated in cell cycle 
arrest, apoptosis and growth suppression instead (Frank et al., 2009). CDKN1A (cyclin-
dependent kinase inhibitor), DEDD2 (a transcription factor) and TNFAIP3 (a tumor necrosis 
factor) are three of the pro-apoptotic and growth-suppressive genes whose expression was 
increased following EO-treatment (Frank et al., 2009). Overall, 30 different genes associated 
with these processes were reported to have been upregulated by the EO (Frank et al., 2009). 
Furthermore, the study showed the effects were only observed in cancer cells without affecting 
the surrounding, noncancerous tissues (Frank et al., 2009). 
 The cancer-suppressive mechanism of action found in the case of frankincense oil is 
drastically different from that which was seen in a number of previously described oils. The 
discriminatory effect observed with frankincense EO also demonstrated the ability to selectively 
treat bladder cancer cells while leaving normal urothelial cells untouched. Frank et al. (2009) 
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conclude their results require further investigation into other bladder cancer cell lines, however, 
the consistency of their results with other studies may suggest a clinical application as a 
complementary intravesical treatment (treatment supplied via catheterization into the bladder) for 
this type of cancer (Frank et al., 2009). Further characterization of this oil and technique may 
also provide other applications in treatments of cancers found in other regions of the body. 
It should be noted that this study does not suggest a full replacement of current therapies 
(chemotherapy and immunotherapy) with EO-treatment but proposes the treatment as a possible 
alternative in the future (Frank et al., 2009). However, this literature seeks to outline possible use 
of EO in oncology, not just as a replacement of current therapies, but also as an addition or 
compliment to them to improve their outcomes if possible. 
Essential Oil-Induced Cytotoxicity. Similar to the apoptotic approach to combatting 
cancer, cytotoxicity is another viable avenue of treating existing cancers and may serve as 
another means by which EOs could be applied oncologically. While cytotoxicity may lead to the 
onset of apoptosis, the term itself pertains to a state of toxicity to the cell which may hinder the 
cell’s growth, function, reproduction or overall viability (Weyermann, Lochmann & Zimmer, 
2005). Whereas apoptosis assays may assess damage to cells (such as DNA fragmentation), 
cytotoxicity assays generally assess parameters related to viability and normal function such as 
metabolic activity, ATP production, or cell membrane integrity (Weyermann, Lochmann & 
Zimmer, 2005). 
 A number of EOs have been studied and observed to exhibit significant cytotoxic effects, 
such as EO of Pulicaria jaubertii, Cymbopogon citratus, Porcelia macrocarpa, and Xylopia 
frutescens (Gautam, Mantha & Mittal, 2014). Amidst the studies which observed the cytotoxic 
effects of these plant extracts also came elucidation of a number of oil constituents whose 
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cytotoxic effects in in vivo studies on cancer cell lines have been well-characterized. These 
include geraniols, perillyl alcohol, d-limonene, thymol, citrine, and a number of other 
compounds (Gautam, Mantha & Mittal, 2014). However, their passage into clinical applications 
is relatively limited; whereas perillyl alcohol has passed through some early stages of human 
clinical trials, many of these chemicals have not yet even begun to see clinical applications yet 
(Gautam, Mantha & Mittal, 2014). 
 One 2017 study explored cytotoxicity in extracts of Lippia citriodora found in various 
regions of Morocco. The study showed the EO to have strong cytotoxic effects on a murine 
mastocytoma cell line at relatively low concentrations (IC50 ranging 7.75 to 13.25 µg/mL, 
compared to other statistically significant concentrations as high as 90 µg/mL discussed in this 
review) (Oukerrou, Tilaoui, Mouse, Bouchmaa & Zyad, 2017). The information of interest in 
this study was not just cancer suppression via apoptosis, but also suppression via reduction of 
cellular activity and viability. 
Similar results were observed and published in Toxicological Research by Lee in 2016. 
α-zingiberene, ar-curcumene and β-sesquiphellandrene comprise the greater quantity of ginger 
essential oil in Lee’s study, of which α-zingiberene was of special interest for its apparent 
cytotoxicity (Lee, 2016). Two cervical cancer cell lines, HeLa and SiHa, as well as breast cancer 
cell line MCF-7 and leukemia cell line HL60 were used for cytotoxicity screening in which 
81.5% and 86% inhibition were observed, respectively, in the presence of 200 µg/mL α-
zingiberene, with a spectrum of other inhibition percentages observed in a dose-dependent 
pattern (Lee, 2016). The MTT metabolic activity assay was used here to probe cell viability over 
time following treatment. The MTT assay is a type of colorimetric cytotoxicity screen in which 
regular metabolic activity of cells reduces a salt (3-(4,5-dimethylthiazol-2-yl)-2,5-
CHEMOPREVENTION AND SUPPRESSION OF CANCER 21 
diphenyltetrazolium bromide in this case) into a blue product, formazan, which can be measured 
spectrophotometrically to quantify metabolism and assess cell viability (Weyermann, Lochmann, 
Zimmer, 2005). 
 Among Lee’s most interesting findings was that the IC50 value (the amount of a drug 
required to halve the activity of a biological process) of α-zingiberene alone was actually 
significantly higher than that of entire ginger EO in all cell lines assessed, perhaps due to the 
presence of other chemical constituents with similar effects or synergistic activity between 
constituents (Aykul & Martinez-Hackert, 2016; Lee, 2016). Therefore, while it may seem 
desirable to identify active compounds within EOs and purify or manufacture these components 
alone as treatment additives, results such as these suggest that a degree of effectiveness may be 
lost in doing so. The complex chemical fingerprints of each EO may have more to offer than 
currently understood. 
 Cisplatin, a powerful chemotherapeutic medication, was used as a control for this 
viability experiment. In all cell lines studied, entire or “general” ginger EO was found to produce 
inhibitions more similar to cisplatin than α-zingiberene alone, except in the case of SiHa cells, in 
which the EO actually held an IC50 value approximately 20 µg/mL less than that observed with 
cisplatin (Lee, 2016). Although this result alone certainly could not serve to support ginger EO 
as a replacement to cisplatin, it may be interpreted that the consistent data provided here suggests 
this extract may be a viable addition to current treatment methods if a functional clinical 
application were developed and these laboratory results able to translate to the organism-level. 
 Cytotoxicity is not a foreign concept in the field of EO research. Gautam, Mantha and 
Mittal alone report over fifty EOs for which varied levels of cytotoxicity has been a major 
finding in other researchers’ publications (2014). The quantification also delineates cytotoxicity 
CHEMOPREVENTION AND SUPPRESSION OF CANCER 22 
separately from antiproliferative activity and inhibitory activity, listing dozens of other EOs 
under these categories as well (Gautam, Mantha & Mittal, 2014). As mentioned, the 
phenomenon of cytotoxicity is a separate entity from apoptosis, yet greatly related to it. Thus, a 
proper look at possible implementations of EO in cancer suppression requires assessment of 
effects on both. As shown by a number of researchers investigating a variety of oils from various 
plant sources, the cytotoxic effects mediated by EO mirror apoptotic effects previously 
described, signifying a possible promising clinical application. 
Essential Oils and Chemoprevention 
Antioxidant Effect. Use of EO alongside current practices to combat existing cancers is 
an incontrovertibly important application of the natural product. Nonetheless, extension of their 
use into the realm of prevention is another face of this coin which warrants significant attention. 
Along that vein, researchers have investigated the antioxidant activity and cancer-preventative 
effects of a number of EOs in recent years. 
One such investigation was conducted focusing on antioxidant effects, among other 
activities, of EO extracted from Cnidium officinale  and Ligusticum chuanxiong. Jeong et al. 
concluded EOs from these two plants may counteract ultraviolet B-induced damage to DNA and 
reduce apoptosis via their constituents’ significant abilities to quench free radicals (Jeong et al., 
2009). Reducing the opportunity of these free radicals to react with cell components reduces the 
risk of events such as double-strand DNA breaks and subsequent mutations or chromosomal 
rearrangements which amplify carcinogenicity (Jeong et al., 2009). Of course, UVB-induced 
damage mainly afflicts the skin, though cancers which begin in the skin may quickly metastasize 
and become life-threatening. Additionally, estimations posit that the lifetime risk of developing 
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invasive melanoma has risen from 1 in 1,500 in the 1930’s to 1 in 74 as of recently; these details 
are increasingly pertinent (Rigel & Carucci, 2008). 
EOs distilled from C. officinale  and L. chuanxiong were tested for their abilities to 
scavenge for free radicals and ROS. The ABTS and DPPH assays are two commonly employed 
methodologies used to assess antioxidant potential of a given compound or reagent (EO in the 
case of this experiment) in which a stable free radical chromogen species is exposed to the 
possible antioxidant and its irreversible reduction by the antioxidant can be detected by a color 
change detected via spectrophotometry (Kedare & Singh, 2011). These assays were carried out 
using the aforementioned plant extracts to investigate dose-dependent radical scavenging ability 
in various EOs, with abilities ranging from 2% activity (measured as the proportion of DPPH or 
ABTS radical quenched and decolorized, analyzed spectrophotometrically) at concentrations of 
0.32 µg/mL to as high as 95% activity at 40 µg/mL (Jeong et al., 2009). Although this test was 
conducted in vitro, and thus cannot fully represent actual in vivo events, the results shed light on 
the chemical properties of these EOs and suggest they may possess similar activity in the greater 
framework of a cell, tissue, and organism. The similarities in chemical composition between oils 
also brings with it the possible translational nature of these results among various EOs. 
Further characterization of the protective effects of these EOs was found in DNA 
migration assays, which allowed extension of the previous test into the context of an entire cell. 
The migration assay used in this study was very similar to the phenomenon of DNA laddering 
previously discussed. Cells were exposed to UVB light in the presence of each separate EO and 
in the absence of either. Gel electrophoresis of DNA isolated from these cells showed dramatic 
fragmentation of DNA in UVB-exposed cells in the absence of either EO compared to those cells 
in the presence of EO (Jeong et al., 2009). The dramatic reduction of DNA damage following oil 
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treatment further elucidated the antioxidant and protective nature of the extracts of  C. officinale  
and L. chuanxiong.  
The promising results of the antioxidant activity of C. officinale  and L. chuanxiong in the 
previously described study point to a possible use of their EOs as preventative measures. As 
damage to DNA sets off the process of carcinogenesis, the reduction or prevention of this 
deleterious event confers the ability to reduce or evade the onset of cancer development. Another 
study brings this investigation a step further and demonstrated the ability of monoterpene perillyl 
alcohol to inhibit skin photocarcinogenesis in mouse models following topical application prior 
to UVB exposure (Pavithra et al., 2019). Monoterpene perillyl alcohol is a major component of a 
number of EOs, including peppermint, spearmint, cherries, sage, gingergrass, caraway, and other 
plants (Pavithra et al., 2019). The study showed a significant delay in tumor appearance, as well 
as a 25-35% reduction in overall melanoma incidence in treated mice (Pavithra et al., 2019). 
Though this study explored different essential oils than the previous study, it pulls the 
antioxidant and mutagen-combatant effects of EOs from the domain of reactions in 96-well 
plates into more clinically applicable context of murine studies. 
However, it would be unwarranted to assume the auspicious results demonstrated here 
were a perfect representation of all EOs. Of course, plants vary greatly in respect to many 
aspects- size, shape, growth conditions, aroma, taste, and a plethora of other qualities. Thus, their 
EOs likely vary in a similar manner, even with certain compounds (such as various terpenes) 
being common from oil to oil.  
An understanding of an even broader scope of antioxidant activity in a wider range of 
EOs may be garnered from other similar studies. The free radical scavenging ability of a variety 
of EOs from a variety of plant sources were analyzed in one such study, also implementing the 
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DPPH assay alongside two other radical-scavenging assays: the beta-carotene bleaching test and 
the PCL method. These three methods were selected for their high performance in assessing the 
activities of both lipophilic and hydrophilic compounds which allows a more accurate 
comparison between oils even though they may vary in their compositions (Sacchetti et al., 
2005). While this study highlighted Cymbopogon citratus (lemon grass) EO as particularly high-
performing in antioxidant activity (as well as antimicrobial activity) a number of other EOs also 
showed high percentages of radical-scavenging activity, including oils from Cananga odorata, 
Rosmarinus officionalis (rosemary), and Curcuma longa (turmeric) (Sacchetti et al., 2005). This 
study probes a single characteristic across a wide scope of EOs and illuminates the large number 
of oils with promising antioxidant activity. Although the study showed relatively low activity in 
some extracts, a key trend is still visible in this study; the antioxidant ability of EOs is not an 
isolated incidence in one oil and the potential of these extracts to prevent cellular damage is 
seemingly significant and thus clinically relevant (Sacchetti et al., 2005). 
Translational modulation of genes implicated in antioxidant activity is another area in 
which EO use may have profound impact upon reduction of oxidative stress caused by ROS 
(Sporn & Liby, 2012). Nuclear factor erythroid 2 factor 2 (Nrf2) is a transcription factor which 
mediates the expression of a number of antioxidant products used to combat oxidative damage 
within the cell (Sporn & Liby, 2012). By binding to sequences known as antioxidant response 
elements on DNA, Nrf2 regulates more than 100 genes producing effects such as reduction of 
nitric oxide synthase expression (reducing levels of this molecule in the cell) or induction of 
catalase expression (an enzyme which breaks down hydrogen peroxide) (Sporn & Liby, 2012). 
Among other protein inductions are those of glutathione, a major electrophile scavenger and 
important protector of the cell from oxidative stress (Sporn & Liby, 2012). As such, the Nrf2 
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pathway is implicated in a variety of cellular activities, including protection from xenobiotics, 
normal homeostatic regulation, apoptosis and inflammation-response (Sporn & Liby, 2012). 
Nrf2-knockout mice show increased incidence of cancer development and serve as a 
testament to this pathway’s involvement in tumor suppression (Sporn & Liby, 2012). Nrf2 
activation produces increased chemopreventive action by the proteins produced by the genes the 
pathway mediates; Nrf2 has thus been well studied in the context of cancer research and is an 
important facet of possible EO use in oncology as well (Sporn & Liby, 2012). 
Oregano EO was shown in a 2016 study using porcine intestinal cells to upregulate a 
number of genes mediated by Nrf2, including superoxide dismutase 1 (SOD1), gamma-
glutamylcysteine ligase (GCLC and GLCM) and catalase (CAT), each of which holds a different 
role in antioxidant activity within the cell (Zou, Wang, Peng & Wei, 2016). In the case of GCLC, 
GLCM and SOD1, mRNA expression was observed to increase in a dose-dependent manner with 
treatment concentrations of the EO ranging from 2.5 to 10 µg/mL (Zou, Wang, Peng & Wei, 
2016). Furthermore, the Nrf2 dependency of the observed genetic modulation was demonstrated 
via Nrf2 downregulation using Nrf2 siRNA to reduce its mRNA expression to approximately 
half of its normal level; the previously described increases in SOD1, GLCM and GCLC mRNA 
expression were subsequently reduced following Nrf2 knockdown, highlighting their 
dependency on the protein’s mediation in their own expression (Zou, Wang, Peng & Wei, 2016). 
Similar results were observed in another 2016 study on red ginseng EO in which 
increased nuclear localization of Nrf2 (indicative of increased gene-regulatory activity) and 
upregulation of a number of genes was observed (Bak et al., 2016). Heme oxygenase 1 (HO-1), 
an antioxidant enzyme involved in heme catabolism, and NADPH-Quinone dehydrogenase 1 
(NQO1), an enzyme which reduces and detoxifies quinones and their derivatives, are among the 
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genes for which increased protein expression was observed via Western blotting (Bak et al., 
2016). These proteins are considered phase II antioxidant enzymes needed for carcinogen 
detoxification, which is believed to be mediated by the Nrf2 pathway through Nrf2 binding to the 
antioxidant response elements found in their genes’ promoters (Bak et al., 2016). 
Whereas normal physiological conditions keep Nrf2 relatively inactive by binding to a 
protein called Keap1, stimulation (such as oxidative stress) causes dissociation and translocation 
of Nrf2 to the nucleus where it binds the response elements in gene promoters and increases their 
expression (Bak et al., 2016). In a manner similar to that with the oregano EO, tests were 
conducted to link the Nrf2 pathway to these phase II enzymes. A luciferase assay using the 
antioxidant response element sequence as the sequence of interest was conducted and showed 
increased luciferase activity at higher EO concentrations (Bak et al., 2016). Additionally, 
increased EO concentrations yielded increased concentrations of nuclear Nrf2 protein (detected 
by Western blotting), and a decrease of cytoplasmic Nrf2 protein, suggesting increased 
translocation of the protein with higher doses of the EO (Bak et al., 2016). Nrf2 protein levels 
from whole cell lysate increased with dose increases as well, showing an overall protein 
upregulation in addition to its translocation (Bak et al., 2016). Collectively, this data suggested a 
strong link between the Nrf2 pathway and its regulation of these antioxidant and cell-protective 
enzymes as a result of red ginseng EO treatment (Bak et al., 2016). 
Anti-metastatic. Amidst the desire to prevent and treat cancers is also found the desire to 
prevent its spreading via metastasis. Local effects on the primary tissue affected by a tumor 
certainly carry the weight of their possible effects and inhibitions of normal physiology in the 
area they are found, but metastasis amplifies these effects and brings with it the dangers of multi-
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systemic dysfunction. In the interest of preventing this event’s occurrence, it is worth elucidating 
EOs possible use as antimetastatic agents in a clinical context. 
A study by Asif et al. (2016) demonstrated apparent anti-metastatic effects on the part of 
EOs extracted from Illicum verum (star anise) plants when used to treat a human colorectal 
carcinoma cell line. Namely, researchers sought to break down EO effects based on the apparent 
changes in three distinct stages of metastasis: local infiltration and invasion, transendothelial 
migration and formation of colonies and proliferation in new tissues (van Zijl, Krupitza & 
Mikulits, 2011). 
Asif et al. (2016) first demonstrated a dose-dependent reduction in cell migration (2016). 
Human carcinoma cells were grown on 6-well plate and scratched with micropipette tips once 
confluent to create a “wound,” or a gap in the cell monolayer. Different wells were subsequently 
treated with various concentrations of EO ranging from 25 to 90 µg/mL or 5-fluorouracil (5-FU) 
as a positive control. 5-FU is a fluoropyrimidine antimetabolite used in the treatment of cancers, 
namely colorectal cancers, which acts via inhibition of thymidylate synthase (Longley, Harkin & 
Johnston, 2003).  Photography of the “wounds” at 0 and 24 hours allowed assessment of cell 
migration to fill the gap to serve as a method of investigating metastatic ability of this cell line 
following EO treatment.  
At 24 hours, the negative control (cells treated with DMSO; no EO) had fully closed the 
gap, whereas cells treated with EO failed to do so (Asif et al., 2016). 25 µg/mL EO treatment 
yielded approximately 10% inhibition of closure, and thus a relatively low amount of anti-
metastatic activity; 90 µg/mL EO treatment produced a higher level of inhibitory activity with 
46% inhibition of closure (Asif et al., 2016). Treatment with 5-FU produced 81% inhibition, 
which is notably larger than the inhibition by EO (Asif et al., 2016). Nonetheless, 5-FU’s 
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established use as an anticancer drug allows it to serve well as a positive control and would be 
expected to hinder growth and migration significantly. Although the level of inhibition observed 
with the high dose of EO was less than that observed with the anti-cancer drug (46% versus 
81%), the dose-dependent inhibition that was nevertheless detected points to promising use of 
EO in pursuit of anti-metastatic treatments.  
Asif et al. (2016) used a similar approach to investigate colony formation and cancer’s 
ability to proliferate in distant tissues following metastasis. This investigation explored the role 
EO treatment may play in reducing this event and its effects by exposing cells to EO and then 
assessing their ability to grow into colonies thereafter (Asif et al., 2016).  
Results of this experiment showed a high degree of similarity of EO treatment to the 
positive control, 5-FU, which showed almost 99% inhibition of colony formation (99% of cells 
were unable to grow into clusters of more than 50 cells) (Asif et al., 2016). Whereas 25 µg/mL 
EO-treatment produced approximately 18% inhibition of colony formation, 90 µg/mL treatment 
presented with 80% inhibition, closely mirroring the effects observed with 5-FU (Asif et al., 
2016). While further studies would certainly be needed to improve purity of EOs and develop 
and refine their application techniques for future use (such as topically, injection, infusion, etc.), 
the results of Asif et al. (2016) show a promising possible means of reducing or arresting tumor 
metastasis at multiple steps of its invasive process.  
Conclusion 
 Cancer research is an ever-prevalent and ever-important field of investigation into which 
billions of dollars flow each year. The face of oncology is continuously changing, and in recent 
years researchers and patients alike have taken on a new interest in EOs as a possible means of 
natural, low-cost and scientifically based methods of treatment in the modern era. This interest 
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has, understandably, resulted in innumerable in vitro studies into antioxidant, anti-metastatic, 
cytotoxic and apoptotic effects mediated by EOs in attempts to illuminate ways in which these 
extracts may be applied medicinally in the prevention and treatment of cancer. As research 
moves forward, more and more in vivo studies are seeing the light and offer hope of upcoming 
clinical applications of these oils alongside current treatment methods. 
 EOs are complex in nature due to their unique chemical constituents, which vary even 
based on growth conditions. Similarly, cancer is an incredibly complex disease for which a 
complex treatment must be molded. Although current applications of EO in oncology are 
currently fairly limited and are mostly confined to aromatherapeutic and means of relief as of 
now, a number of studies which have helped clarify the biochemical actions EOs have within the 
cell point to promising chemopreventative and cancer suppressive uses for the natural extracts.  
 Future research will likely continue to grow the number of in vitro studies in order to 
grow the clinical relevance of such an application. Nonetheless, studies have shown dramatic 
abilities in certain oils and oil constituents to inhibit uncontrolled cell growth, induce apoptosis, 
quench ROS and free radicals, and even affect gene expression. EOs are not intended or hoped to 
serve as a replacement to current therapies, but rather as a compliment. However, if the effects 
described here can be translated clinically, they may offer the ability to improve current 
diagnosis outlooks in a significant and affordable way. 
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